Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct 4;50(41):9722-6.
doi: 10.1002/anie.201104504. Epub 2011 Aug 30.

Asymmetric total synthesis of the epoxykinamycin FL-120 B'

Affiliations

Asymmetric total synthesis of the epoxykinamycin FL-120 B'

Stephen S Scully et al. Angew Chem Int Ed Engl. .

Abstract

Turn up the heat: An asymmetric total synthesis of the epoxykinamycin FL-120B’ is reported. The synthesis establishes a route to epoxide-containing diazobenzofluorenes which could potentially serve as monomers to the dimeric lomaiviticins. Key steps include Sharpless asymmetric epoxidation, Stille coupling, and intramolecular Friedel-Crafts acylation of atropisomeric carboxylic acids at elevated temperatures to construct the FL-120B’ core structure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative diazobenzofluorene natural products.
Figure 2
Figure 2
Biomimetic approaches to the lomaiviticins.
Figure 3
Figure 3
Retrosynthesis for FL-120B’ (4). P = protecting group, MOM = methoxymethyl. TBS = t-butyldimethylsilyl.
Figure 4
Figure 4
Variable temperature (VT) 1H NMR (500 MHz, CD3NO2) stackplot of acid 20b.
Scheme 1
Scheme 1
Enantioselective synthesis of epoxide 13. t-BuOOH (2.0 equiv), Ti(Oi-Pr)4 (0.10 equiv), L-DIPT (0.13 equiv), 4Å MS, CH2Cl2, 0 °C, 60 h. DIPT = diisopropyl tartrate, MS = molecular sieves.
Scheme 2
Scheme 2
Forward synthesis to carboxylic acids 20a–c. a) Na2S2O4 (6.0 equiv), Et2O, H2O, rt, 10 min; b) MeI (6.0 equiv), K2CO3 (6.5 equiv), DMF, 0 °C→rt, 18 h, 66% yield (2 steps); c) (SnBu3)2 (1.3 equiv), Pd(PPh3)4 (0.1 equiv), toluene, 110 °C, 48 h, 74%; d) 11 (1.0 equiv), 10 (1.1 equiv), Pd2(dba)3·CHCl3 (0.1 equiv), AsPh3 (0.3 equiv), CuCl (0.6 equiv), i-Pr2NEt (1.1 equiv), MeCN, 72 °C, 3 h, 90% yield; e) Ac2O (30 equiv), pyr, rt, 6 h; f) Super-Hydride (LiHBEt3) (2.1 equiv), THF; 74% (2 steps) g) 18a: Ac2O (30 equiv), pyr, rt, 3 h, 96%; 18b: ClC(O)(CH2)3N3 (1.1 equiv), CH2Cl2 / pyr, 0 °C, 1 h, 73%; 18c: Boc2O (5.0 equiv), DMAP (5.5 equiv), CH2Cl2, rt, 4 h, 93%; h) HF·pyr (excess), THF / pyr, 0 °C; 15–20 h; i) DMP (2.0 equiv), pyr (2.1 equiv), CH2Cl2, rt, 3–5 h, 73–88% (2 steps); j) NaClO2 (9 equiv), NaH2PO4 (8 equiv), 2-methyl-2-butene (excess), t-BuOH / H2O, 0 °C→rt, 2–3 h, 78–90%. Dba = dibenzylideneacetone, DMF = N,N-dimethylformamide, pyr = pyridine, Boc = t-butoxycarbonyl, DMAP = N,N-dimethyl-4-aminopyridine, DMP = Dess-Martin periodinane.
Scheme 3
Scheme 3
Proposed cyclization manifolds for intramolecular Friedel-Crafts acylation and lactone formation.
Scheme 4
Scheme 4
Completion of FL-120B’ (4). a) TBDPSCl (15 equiv), imid (20 equiv), DMAP (0.5 equiv), CH2Cl2, rt, 20 h, 84%. b) MsNHNH2 (25 equiv), TFA (8 equiv), i-PrOH / H2O, 72 h; c) CAN (3 equiv), CH3CN / pH 7 buffer, 0 °C, 1 h; d) NEt3 (10 equiv), CH2Cl2, rt, 1 h, 16% (3 steps); e) HF·pyridine (excess), THF, 0 °C→rt, 3 h, 51%. TBDPS = t-butyldiphenylsilyl, imid = imidazole, Ms = methanesulfonyl, CAN = cerium (IV) ammonium nitrate.

References

    1. For a recent review on diazo natural products, see: Nawrat CC, Moody CJ. Nat. Prod. Rep. 2011;28:1426–1444.

    1. Ito S, Matsuya, T T, Omura S, Otani M, Nakagawa A. J. Antibiot. 1970;23:315–317. - PubMed
    2. Hata T, Omura S, Iwai Y, Nakagawa A, Otani M. J. Antibiot. 1971;24:353–359. - PubMed
    3. Omura S, Nakagawa A, Yamada H, Hata T, Furusaki A. Chem. Pharm. Bull. 1973;21:931–940. - PubMed
    1. For a review on the biosynthesis of diazobenzofluorene natural products, see: Gould SJ. Chem. Rev. 1997;97:2499–2509.

    1. Cone MC, Seaton PJ, Halley KA, Gould SJ. J. Antibiot. 1989;42:179–188. - PubMed
    2. Seaton PJ, Gould SJ. J. Antibiot. 1989;42:189–197. - PubMed
    1. Lin HC, Chang SC, Wang NL, Chang LR. J. Antibiot. 1994;47:675–680. - PubMed
    2. Young J-J, Ho SN, Ju WM, Chang LR. J. Antibiot. 1994;47:681–687. - PubMed

Publication types

MeSH terms

LinkOut - more resources